Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 8, 2002, Pages 1519-1527

  Stockbrugger R W ^a   Schoon, E J ^a   Bollani, S ^b   Mills, P R ^c   Israeli, E ^d   Landgraf, L ^e   Felsenberg, D ^e   Ljunghall, S ^f   Nygard, G ^f   Persson, T ^f   Graffner, H ^f   Bianchi Porro, G ^b   Ferguson, A ^g  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MILAN   (Italy)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f ASTRAZENECA R AND D   (Sweden)

^g ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID;

ABSORPTIOMETRY; ADULT; AGE; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CROHN DISEASE; DIAGNOSTIC IMAGING; DRUG ACTIVITY; DRUG USE; FEMALE; GENDER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOPENIA; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SPINE RADIOGRAPHY; SPINE SCINTISCANNING; SYMPTOM; VERTEBRA FRACTURE; AGE DISTRIBUTION; AGED; EUROPE; ISRAEL; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PATHOPHYSIOLOGY; RADIODENSITOMETRY; SPINE FRACTURE;

ADULT; AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS, STEROIDAL; BONE DENSITY; CROHN DISEASE; DENSITOMETRY, X-RAY; EUROPE; FEMALE; FRACTURES, SPONTANEOUS; GLUCOCORTICOIDS, SYNTHETIC; HUMAN; ISRAEL; MALE; MIDDLE AGE; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; SPINAL FRACTURES; SUPPORT, NON-U.S. GOV'T; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; STEROIDS;

EID: 0036668712     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01317.x     Document Type: Article

References (44)

1. Metabolic bone assessment in patients with inflammatory bowel disease
2. Reduced bone density in patients with inflammatory bowel disease
3. Osteoporosis in patients with inflammatory bowel disease
4. Low bone mineral density in patients with inflammatory bowel disease
5. Osteoporosis and determinants of bone density in patients with Crohn's disease
6. Osteopenia and osteoporosis in Crohn's disease
7. A controlled study of bone mineral density in patients with inflammatory bowel disease
8. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
9. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population-based study
10. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease
11. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease
12. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease
13. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease
14. Bone loss in patients with inflammatory bowel disease: A prospective study
15. Bone loss in patients with inflammatory bowel disease is less than expected
16. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis
17. Altered bone metabolism in inflammatory bowel disease
18. Bone mineral density in patients with Crohn's disease during long-term treatment with azathioprine
19. Femoral neck osteopenia in patients with inflammatory bowel disease
20. Development of a Crohn's disease activity index
21. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
22. Morphometric analysis of spine X-rays for diagnosis of osteoporotic fractures
23. Assessing vertebral fractures
24. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group
25. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease
26. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease
27. Osteomalacia after small-intestinal resection
28. Alterations in bone metabolism in children with IBD: An in vitro study
29. Production of inflammatory cytokines in the intestinal lamina propria
30. Bones and Crohn's disease: Cytokines, a missing link?
31. Local and systemic factors in the pathogenesis of osteoporosis
32. Cytokines and bone
33. Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: The EVOS study
34. The incidence of fracture among patients with inflammatory bowel disease. A population-based study
35. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
36. Do men and women fracture bones at similar densities?
37. Endogenous hormones and the risk of hip and vertebral fractures among older women
38. Inflammatory bowel disease. An epidemiological and genetic study
39. Anastomosis ileoanal con reservorio en J. Evolucion de la tecnica y resultados
40. Vertebral compression fractures in pediatric patients with Crohn's disease
41. Bone structure in patients with low bone mineral density with or without vertebral fractures
42. Granulomatous osteonecrosis in Crohn's disease
43. Osteonecrosis in a patient with Crohn's disease unrelated to corticosteroid use
44. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease